1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer

Transparent process

 

  1. Transparent Review
    Referee reports are published in full but without attribution; no confidential comments; authors can exclude referees.
  2. Fast Process
    Editorial decisions on average within a week, referee comments within a month, publication possible in 2 weeks.
  3. Straightforward Submission
    No journal-specific formatting is required at submission.
  4. Scooping Protection
    Similar findings published by others during review or revision are not a criterion for rejection.
  5. Referee Cross-Commenting
    Referees comment on one another’s reports before the editor makes a decision.
  6. Single Round
    Papers rarely undergo more than one major round of revision; more than 90% of invited revisions are published.
  7. Informed Evaluation
    Detailed editorial decisions supported by the Editorial Board. Authors can discuss manuscripts with editors at any stage.
  8. Manuscript transfers
    Authors can select to transfer manuscripts with referee reports between the EMBO publications.
  9. Source Data
    Authors can publish source data alongside figures. Supplementary information is restricted to essential data supporting key claims.
  10. Cite the Source
    Reference to specific findings should cite research papers. Journals have unlimited reference lists.

Meet the EMBO Editors

May

5 - Cell Symposia: Mitochondria: from Signaling to Disease, PT - Barbara Pauly (ER)
5 - EMBO Conference: Autophagy: Molecular mechanism, physiology and pathology, NO - Nonia Pariente (ER) & Anke Sparmann (EJ)
7 - CSH: The Biology of Genomes, USA - Thomas Lemberger (MSB)
8 - EMBO Conference: Chromatin and Epigenetics, DE - Esther Schnapp (ER):
10 - Keystone: Pathogenesis of Infectious Disease (E1), BR - Karin Dumstrei (EJ)
13 - CSH: The Ubiquitin Family, USA - Hartmut Vodermaier (EJ)
24 - Adult Stem Cells in Aging, Diseases, and Cancer, DE - Barbara Pauly (ER)
27 - Eigth Microsymposium on Small RNAs, AT - Anne Nielsen (EJ)
29 - CSH: Immunity & Tolerance, USA - Karin Dumstrei (EJ)